Market Overview:
The global anastrozole tablets market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The hospital segment is expected to account for the majority share of the global anastrozole tablets market in 2018 and is projected to maintain its dominance throughout the forecast period. The drug store segment is projected to grow at a higher CAGR as compared to other application segments during the forecast period. North America accounted for majority share of the global anastrozole tablets market in 2017 and this trend is anticipated to continue throughout the forecast period.
Product Definition:
Anastrozole tablets are used to treat breast cancer in women who have had their menopause. It is a type of hormone therapy called an aromatase inhibitor. Anastrozole tablets work by stopping the body from making estrogen, which can help slow the growth of breast cancer cells.
1mg:
Anastrozole, also known as 1mg or letrozol, is an aromatase inhibitor used in the treatment of breast cancer. It works by decreasing the amount of estrogen that is converted to oestrogen in the body. Oestrogen is responsible for causing breast cancer cells to grow and multiply. Anastrozole has been approved by Health Canada and The U.
Others:
Others are the other ingredients in the anastrozole tablets formulation. The Others segment includes inactive ingredients such as binders, disintegrants, fillers and flow agents. Others segment is expected to grow at a CAGR of XX% during forecast period owing to its increasing usage in various end-use industries including pharmaceuticals and nutraceuticals among others.
Application Insights:
Hospital was the dominant application segment and accounted for a revenue share of around 60.0% in 2017. Rising awareness about breast cancer among women & increasing incidences of breast cancer across the globe are some of the factors responsible for market growth in this segment. Breast cancer is one of the most common cancers found among women, accounting for approximately 40% to 50% overall incidence rate globally every year.
Drug stores are expected to be fastest-growing application segment owing to high product demand from emerging countries such as India, China and Brazil which account for a relatively smaller share in global anastrozole tablets market due to low healthcare spending levels compared to western countries such as U.S.
Regional Analysis:
North America was the largest regional market in 2017 owing to high incidence of breast cancer. Presence of key manufacturers such as Pfizer, Inc.; F. Hoffmann-La Roche AG; and Merck & Co., Inc.; and availability of branded anastrozole tablets are some factors responsible for its large share. Moreover, increasing awareness about various treatment options is also expected to drive the region’s growth over the forecast period.
Asia Pacific is anticipated to be one of the fastest growing regions during the forecast years on account of rising geriatric population base in countries such as Japan and China which increases their susceptibility towards breast cancer development thereby driving demand for anti-estrogen drugs leading to anastrozole tablets high demand in this region over forecast period).
Growth Factors:
- Increasing incidence of breast cancer: The incidence of breast cancer is increasing at an alarming rate across the globe. This is expected to drive the demand for Anastrozole tablets in the coming years.
- Growing awareness about early detection and treatment options: There is a growing awareness among people about the importance of early detection and treatment options for breast cancer. This is likely to boost demand for Anastrozole tablets in the near future.
- Rising popularity of adjuvant therapy: Adjuvant therapy, which involves using additional drugs or treatments after surgery, has gained popularity in recent years due to its ability to improve survival rates in patients with breast cancer. This is likely to fuel demand for Anastrozole tablets in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Anastrozole Tablets Market Research Report
By Type
1mg, Others
By Application
Hospital, Drug Store
By Companies
AstraZeneca, Zydus Pharmaceuticals, Teva, Hikma Pharmaceuticals, Natco Pharma, Fresenius Kabi, Accord Healthcare, Mylan, Cipla, Apotex, AstraZeneca, Chongqing Huapont Pharmaceutical, Zhejiang Wansheng Pharmaceutical, Yangtze River Pharmaceutical Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
148
Number of Tables & Figures
104
Customization Available
Yes, the report can be customized as per your need.
Global Anastrozole Tablets Market Report Segments:
The global Anastrozole Tablets market is segmented on the basis of:
Types
1mg, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca
- Zydus Pharmaceuticals
- Teva
- Hikma Pharmaceuticals
- Natco Pharma
- Fresenius Kabi
- Accord Healthcare
- Mylan
- Cipla
- Apotex
- AstraZeneca
- Chongqing Huapont Pharmaceutical
- Zhejiang Wansheng Pharmaceutical
- Yangtze River Pharmaceutical Group
Highlights of The Anastrozole Tablets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 1mg
- Others
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Anastrozole Tablets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Anastrozole tablets are a medication used to treat breast cancer. It is an aromatase inhibitor, which means it blocks the action of estrogen in the body. This can help to reduce the growth of cancer cells and improve your overall health.
Some of the major players in the anastrozole tablets market are AstraZeneca, Zydus Pharmaceuticals, Teva, Hikma Pharmaceuticals, Natco Pharma, Fresenius Kabi, Accord Healthcare, Mylan, Cipla, Apotex, AstraZeneca, Chongqing Huapont Pharmaceutical, Zhejiang Wansheng Pharmaceutical, Yangtze River Pharmaceutical Group.
The anastrozole tablets market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Anastrozole Tablets Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Anastrozole Tablets Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Anastrozole Tablets Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Anastrozole Tablets Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Anastrozole Tablets Market Size & Forecast, 2020-2028
4.5.1 Anastrozole Tablets Market Size and Y-o-Y Growth
4.5.2 Anastrozole Tablets Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 1mg
5.2.2 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Anastrozole Tablets Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Anastrozole Tablets Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 1mg
9.6.2 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 1mg
10.6.2 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 1mg
11.6.2 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 1mg
12.6.2 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 1mg
13.6.2 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Anastrozole Tablets Market: Competitive Dashboard
14.2 Global Anastrozole Tablets Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AstraZeneca
14.3.2 Zydus Pharmaceuticals
14.3.3 Teva
14.3.4 Hikma Pharmaceuticals
14.3.5 Natco Pharma
14.3.6 Fresenius Kabi
14.3.7 Accord Healthcare
14.3.8 Mylan
14.3.9 Cipla
14.3.10 Apotex
14.3.11 AstraZeneca
14.3.12 Chongqing Huapont Pharmaceutical
14.3.13 Zhejiang Wansheng Pharmaceutical
14.3.14 Yangtze River Pharmaceutical Group
